Ralph Herbst

Ralph Herbst serves as Chief Strategy Officer at Asklepios BioPharmaceutical, Inc. since July 2023, focusing on leadership in strategy and operational effectiveness. Prior to this role, Ralph held various senior leadership positions at Bayer Pharmaceuticals from April 2012 to July 2023, including Head of Strategy Implementation & Business Planning for the Cell & Gene Therapy Unit, where strategic collaborations and business model innovations were emphasized. Ralph also has extensive experience in corporate development and technology management from previous roles within Bayer and Covestro, along with advisory contributions at pfm medical ag. Educational credentials include a Master of Science in Chemical Engineering from RWTH Aachen University, an Executive MBA from Rotterdam School of Management, and various advanced business degrees from prestigious institutions, showcasing a robust foundation in engineering and business management.